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Arguments are presented leading to the conclusion that two major factors contribute to the potency of inhibition of DNA-polymerase activity by 
chain-terminating nucleotides. The relative significance of these factors varies with the reaction conditions, particularly with the length of the 
template and the concentration ratio of enzyme (reverse transcriptase or other DNA polymerase) to primer. It is concluded that potent inhibition 
of I-IIV-reverse transcriptase activity under typical in vitro and in vivo conditions arises from different featl:res of the interaction ofchain terminators 
with the enzyme. A new method of testing for the parameter important under in vivo conditions is suggested. 
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1. INTRODUCTION 
The only currently available chemotherapy of I-II\ 
infections is that provided by the use of a nucleoside 
analog, 3’-azidothymidine (review: Cl]). While there are 
serious and limiting side-effects caused by the use of this 
agent, there is also good evidence that it has a positive 
influence on the course of the disease. Other dideoxy 
nucleoside analogs, in particular dideoxy cytidine and 
dideoxy inosine, appear to have similarly beneficial ef- 
fects, with different side-effects. The experience with 
these drugs may be taken as encouragement o proceed 
with the search for alternative and better potential drugs 
from this class of compounds, and to help achieve 
this aim, a detailed knowledge of lheir mode of action 
is needed. 
Most of the nucleoside derivatives which have been 
identified as having potent anti-HIV activity belong to 
the family of 2’,3’-dideoxynucleosides, i.e. they are ana- 
logs of the naturally occurring 2’-deoxynucleosides in 
which the 3’-hydroxyl group has been replaced by an- 
other moiety, in the simplest case by a hydrogen. In 
their triphosphorylated form, they are able to inhibit 
DNA synthesis by DNA-polymerases by incorporation 
of the analog monophosphate at the 3’-end of the 
growing chain, which leads to chain termination. This, 
together with a more potent effect on reverse 
transcriptase than on cellular polymerases, appears to 
be the basis of their inhibitory effect on HIV replication. 
Thus, the derivatives must, after entering the cell in their 
non-phosphorylated form, first be phosphorylated by 
cellular kinases to give the active form of the drug. This 
process is oljviously of great importance, and since 
several kinases of varying specificity are involved, it 
occurs with varying efficiency with the different agents 
available. The problems occurring during pro-drug 
activation will not be discussed here, but it is clear that 
a more rational approach to optimising substrate 
properties towards cellular kinases is desirable. 
Once the nucleoside analog is present in sells in its 
triphosphorylated form, its interaction with the viral 
reverse transcriptase after invasion by I-IIV appears to 
be the crucial factor invoIved in inhibition of viral repli- 
cation. An understanding of the mechanism of this inhi- 
bition, and of the reasons for the specificity of the effect 
for the viral enzyme when compared with cellular DNA 
polymerases is of great importance for the further 
search and development of better nucleoside-based 
drugs. We believe that there may be some misunder- 
standing of the relative importance of different aspects 
of the interactions involved, and also that currently used 
in vitro reverse transcriptase inhibition assays are not 
necessarily appropriate for screening and comparison 
of this class of inhibitors. 
2. THEORY 
Correspon&~rce oddrm: R.S. Goody, Abteilung Biophysik, Max- 
Planck-Institut fClr Medizinische Forschung, Jahnstr. 29,690O Heidel- 
berg, Germany. 
Two main factors appear to sontribute to inhibition 
of DNA polymerases by chain terminators. The first of 
these is competition between the dideoxynucleotide and 
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the natural deoxynucleotide in binding to the enzyme 
and incorporation into the DNA chain. TO examine the 
results of this type of competition in a quantitative ~-WI- 
ner, we consider a system consisting of a template rno1- 
ecule (EDNA or DNA), a primer (tRNA or an oligonu- 
cleotide) and an excess of reverse transcriptase (WT) 
over primer/template complex (WT). This means that all 
potential sites of primer extension are occupied by poly- 
merase molecules, which in turn means that steps invol- 
ving dissociation of the enzyme from completed or ter- 
minated duplexes need not be considered in this analy- 
sis. The situation after addition of a nucleoside tri- 
phosphate complementary to the template can be de- 
scribed formally by the following scheme: 
f dNTP !i 
RI’ + P/T ,- . - RTPIT - RT.P/TedNTP- ,p RT+-dNMP/T 
K PA K” 
Scheme 1. RT is reverse transcriptase, PIT is the primer/template 
complex, dNTP is a deoxynucleotide triphosphate and P-dhlMP is the 
primer which has been extended by addition of one deoxynucleotidc 
monophosphate residue. K,,, is the dissociation constant of the RT+P/ 
T complex, K, is the dissociation constant for dNTP from its complex 
with RT*PIT and k is the rate constant for the transfer of ~NMP to 
the 3’-end of the primer. 
A simiiar scheme applies for a chain-terminator, and 
here we use the constants ici and ki to correspoad to KS 
and 8. We now assume that the template is a ho~~~poly- 
mer, e.g. polyrA, which means that for the shbstrate 
(CITTP), steps 2 and 3 of Scheme 1 occur in a cyclical 
manner until the primer is extended to the length of the 
template. Whether the polymerase dissociates during 
the course of this filling up reaction or not depends on 
the processivity of the enzyme, which is in turn depend- 
ent on the relative rates of the polymerisation reaction 
and the rate of dissociation of the cnzymc from ex- 
tended piimcr/template complexes which still have an 
overhanging 5’4emplatc end, The probability of di$ 
sociation obviously also increases with the length of the 
template, but under the conditions used for this analysis 
such events are of no conscquencc. since fret primer 
e’nds will be rapidly occupied by other rcvcrsc 
transcriptasc molecules. 
Under the conditions dcfincd here, the cffectivc scc- 
and order rate constant defining the rate of inoorpora- 
tion of substrate into the growing chain is ~/PC,. This 
expression is tinalogous to the well-klIowtl k,,,,lK,,,, vuIuc 
in classical cnzymc kinetics. The corresponding cxpres- 
sion for the chain terminator is k,lKi:i, tttd I~C r&tivc 
rate of incorporlrtion of substrlttc end ctmin tcrmin;ttor 
at each position of the tcmplilrc (i.e. for cuch IIIQII(~IIU- 
clcratidc uddcd) is giver1 by the expression: 
where kapp and 1cepp.i are the respective pseudo-first- 
order rate constants for incorporation of substrate and 
chain-terminator, respectively, into the growing chain. 
The probability, p, that smbstrat.e, and not chain termi- 
nator, is incorporated at each step is given by 
(2) 
where p lies between 0and 1. Considering the first posi- 
tion to be filled at the Y-end of the primer, and using 
C, as the concentration of primer bound to template, 
the concentration of substrate incorporated (6,) is given 
by 
c, = CJp 
and at position 2 by 
c, = cQpZ 
and in general for the ch position by 
(4) 
Ci = C@’ (5) 
The sum of the concentrations of substrate incorpora- 
ted at each step gives the amount of substrate incorpo- 
rated (Ci,,,) if the reaction is allowed to go to completion 
in the presence of a chain terminator. This is given by 
c&lc,= iypi = $g; I” p2 f j73 -I- . . . . . . . . p”) 
i=l ‘=: 
(6) 
where IZ is the number of bases with can be added to 
each primer molecule as determined by the length of the 
template. This finite geometric series can be converted 
to the standard form 
i=n 
Ci,,dC,= Z: p( 1 + 12 + /I2 -e .*.. ,.,. ]I”_‘) (7) 
i=l 
whose sum is known to be equal to 
/J((P” - lY(p - 1)) 
and thus 
(8) 
ci,tc = CJI((~,” - l)/@ - 1)) (9) 
WC can then define the relative amounts of substrate 
incorporntcd in the presence and absence of chain tcr- 
minaror (I,, the fractional incorporation) by dividing 
this equation by KS,, which is the concentration of sub- 
stratc which can be incorporated in the rtbscncc of chain 
terminator, by 
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1% = lOOp((/Y - 1)/n@ - 1)) (11) 
A more useful form of the equation uses Y, the ratio of 
the effective rate constants for incorporation of chain 
terminator and substrate (k;,,,i/k~,)* From Eqn. 2, it is 
easy to show that 
October 1991: 
p = ll(r + 1) 02) 
Substituting this in Eqn. 11, we obtain 
ls = lOO(1 - (I/@ + l)>)l)/nr 03) 
A practical form of the equation is obtained by substitu- 
ting for Y in Eqn. 13 using the relationship 
r = lCilil,ilkKiS (14) 
where s and i are the substrate and inhibitor concentra- 
tions, re.rpectively. If we also substitute k,KsIkpC, by the 
parameter k,, which is the relative size of the effective 
second-order rate constants for chain terminator and 
substrate, we obtain the equation 
1, = iOOs( 1 - (l/(lc,i/s + l))“)lnk,i (15) 
3. EXAMPLES 
We can now begin to examine the expected degree of 
chain termination and of inhibition of the extent of 
substrate incorporation in the presence of chain termi- 
nators in different situations with respect to the length 
of the template and the relative concentrations of 
primer/template and enzyme. 
3. I. Short templates 
In the first example, the nature of the template/primer 
complex is such that only 10 nucleotides can be added 
to the primer before the double-stranded region is com- 
plete If WC assume that k, is equal to 1, which appears 
to be the case for AZTTP compared with TTP [2], and 
assume that substrate is present at 1000 times the con- 
centration of chain terminator (AZTTP shows signifi- 
cant inhibition at such relative concentrations in stand- 
ard in vitro assays), p is 0.999, and from Eqn. 5 the 
concentration of chains which reach position 10 on the 
template is 0.999’°C0 or 0,99C,. Thus, 99% of the chains 
are completed, which means that only 1% chain termi- 
nation will have occurred, and if inhibition were defined 
to be the degree of chain termination, it would he 1%. 
This is the parameter which is of potential interest in 
judging the potency of the inhibitor in vivo, since chain 
termination at any position (except he last) will Icad, to 
lack of completion of the new DNA strand. Howcvcr, 
stn1jditrd itivitro trses mcmrc the mount of nuclcoridc 
incorporation, and using Eqn. 15 it can be calculatc$ 
that the incorporation of substrate in the presence of 
chain terminator, I%, is 99.45%. Thus, there will be 
0.55% inhibition of the extent of in.corporation under 
these conditions, which would be barely measurable. At 
a ratio of 1OO:l of substrate to chain terminator, this 
would become 5.3%. 50% inhibition of incorporation 
would be seen at relative concentrations of terminator 
and substrate of ca. 0.2, corresponding to 4 ,&4 if the 
substrate concentration is 20 PM, which is a commonly 
used value. This is 2-3 orders of magnitude higher than 
that seen with AZTTP/TTP, indicating that chain termi- 
nation per se together with subsequent,removal of the 
terminated chain from the pool of growing chains can- 
not be responsible for the potent inhibition seen in in 
vitro tests by AZTTP and other dideoxynucleotides. 
Thus, another factor must be responsible for the potent 
inhibition seen, and this arises from the fact that in the 
in vitro assays, catalytic amounts of enzyme with re- 
spect to primer are used, i.e. there is a large excess of 
primer over enzyme. Under these conditions, the proba- 
ble mode of inhibition is a consequence, of the process- 
ivity of the enzyme. The processivity is determined by 
the relative rates of chain propagation and dissociation 
of the poiymerase from its complex with tem- 
plate/primer. I-Iigh processivity (i.e. a large number of 
kcleotides added in a processive manner without the 
enzyme leaving the RNA-DNA or DNA-DNA com- 
plex) is ensured by a low rate of spontaneous dissocia- 
tion. We [ZJ have measured .this rate to be ca. 0.04 s-I 
at 25°C for a chain-terminated complex in the case of 
HIV-1 reverse transcriptase, or a factor of ca. 10 lower 
from a complex analogous to the ‘dead end’ complex 
described for other polymerases and which is a complex 
formed between template, chain-terminated, primer, po- 
lymerase and the deoxynucleotide triphosphate which 
would have been added next in a template-directed 
manner if chain termination had not occurred. The af- 
finity of the reverse transcriptase-template/primer in- 
teraction is ca. 10” M-’ in such complexes [2], or a 
factor of ca. 10 lower without deoxynucleotide triphos- 
phate. The affinity for non-terminated template/primer 
complexes appears to be similar, at least in the absence 
of dNTP, but under polymerisation conditions, its effec? 
tive affinity is given by its K,,, value, which will be much 
higher than the true dissociation constant (at least with 
short templates), since polymerisation and (prcsuma- 
bly) dissociation from filled up complexes (i.e, blunt 
ends) gives the enzyme a faster way out of this stable 
complex. Thus, an irreversibly terminated template/pri: 
mer complex is a very effective inhibitor of the normal 
cnzyllie-tcmplatclprimcr interaction. 
Such a mode of inhibition has been described in detail 
for the case of herpes implex DNA-polymerase and the 
antiviral agent acyclovir, which functions in its phos- 
phorylatcd form as a chain terminator [31. The antiviral 
action of this malog is thought to arise from this type 
of inhibition. It is thus of intcrcst o consider whether 
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the anti-I-IIV action of AZT and other nucleoside ana- some promising candidates might be eliminated on the 
logs might arise from a similar mechanism. basis of the in vitro test using short templates. It is 
conceiva.ble that a substance which has very good incor- 
3.2. Long templates poration kinetics, which is the important parameter in 
At this point, it is important to realize that there is vivo, and which is also well metabolized by cellular 
a fundamental difference in the concentration relation- kinases, might be missed at an early stage in screening 
ships in the in vitro tests and in cells which have just because it does not form a particularly stable dead end 
been penetrated by HIV. This arises because ach mol- complex, which is the decisive factor for in vitro inhibi- 
ecule of viral RNA has its ‘own’ reverse transcriptase tion, The different possible mechanisms of inhibition 
molecule, whereas in the in vitro tests, each polymerase are also of relevance to studies of the selectivity of 
molecule must move between a large number of poten- AZTTP and similar reagents for reverse transcriptase as 
tial polymerisation sites. If it cannot do this, or only compared to cellular polymerases. Such studies have 
very slowly, because of chain termination by nucleotide also been done using short templates, and might thus 
analogs and formation of a dead end complex, inhibi- give results which do not apply to the in vivo situation 
tion of polymerisation will res’ult because many primer with long templates. 
molecules will never ‘see’ an enzyme molecule. Al- A convenient assay which removes these uncertainties 
though the strategic detail!; of reverse transcription in would be valuable. The most rigorous method, the 
retroviruses are not yet fdiy unuerstood, it seems un- examination of single step kinetics, is not a realistic 
likely that removal of reverse transcriptase molecules approach for screening large numbers of substances. 
from the pool available for polymerisation will contri- The use of long single-stranded templates, although ex- 
bute to the inhibition observed, for the simple reason perimentally less convenient han standard template/ 
that there are at least as many polymerase molecules as primeroomplexes, gives a better approximation to the 
viral RNA molecules. However, this does not, of in vivo situation, since the significance of formation of 
course, alter the fact that chain termination at any stage dead end complexes is reduced, although still not re- 
of transcription will lead to incomplete and presumably moved if catalytic amounts of enzyme are used, which 
non-functional DNA chains. Nevertheless, it seems will normally be the case if the time dependence of the 
likely that potent inhibition can occur in this situation incorporation is to be followed conveniently. However, 
because of the much greater length of the template than it is conceivable to obtain an estimate of the relative 
in the in vitro experiments. If we take the same probabil- rates of incorporation of a chain terminator and a sub- 
ity, p, of incorporation of the natural nucleotide as was strate using Eqn. 15 without the need to follow the 
used in the first example, and then choose a chain length polymerisation reaction at high temporal resolution. 
of 3000 (approximately the number of thymidines which The experimental design would be similar to that used 
are incorporated on reverse transcription of the HIV for the theoretical examples discussed above, i.e. an 
RNA) for the template instead of 10, the probability excess of reverse transcriptase over primer/template 
that termination has not occurred after 1000 bases is would be used, and the amount of substrate incor- 
(0.999)30°0 or 6;a. 0.05, meaning that ca. 95% chain termi- porated after allowing the polymerisation reaction to go 
nation will have occurred, compared to 1% after 10 to completion in the presence and absence of chain 
added nucleotides. The degree of inhibition of nucleo- terminator would be compared. If the 1, is determined 
tide incorporation can be calculated to be ca. 68.4%. at various inhibitor concentrations and constant sub- 
The figure which is relevant for judging the potency in strate concentration, Eqn. 15 can be used in conjunction 
terms of antiviral activity is the degree of chain termina- with one of the commercially available computer 
tion. Thus, if an AZTTP concentration which is 1000th programs which allow non-linear regression fits to 
of the TTP concentration can be achieved in cells prior equations entered by the user (e.g. Grafit) to obtain a 
to invasion by HIV, which seems likely [4], potent inhi- value for k,. This could be done with long or short 
bition should occur. We therefore conclude that inhibi- templates, as long as n, the number of sites at which the 
tion of completion of transcription by low concentra- chain terminator can potentially be added, is known. 
tions of AZTTP is a quantitatively realistic mechanism There are several advantages of the suggested method 
for the antiviral effect of AZT, but that the origin of the of evaluating the properties of chain terminating nucle- 
potent inhibition is not the same as that in the standard otides. Firstly, a parameter is obtained which is an ob- 
in vitro tests. jective measure of the efficiency of addition of the nucle- 
otide monophosphate onto the end of the growing 
4. CONCLUSIONS DNA chain. This is in strong contrast o the parameter 
which is called Ki or alternatively ICso obtained from the 
In pragmatic terms, it is initially not of great impor- standard steady-state assays. This value is purely empi- 
tance which of the two mechanisms for potent inhibition rical and applies only to the exact conditions used for 
is responsible for the antiviral effect of AZT. However, the determination. In particular, it will be clear from the 
in searching for alternative agents, it is possible that above analysis that tilis parameter will vary with the 
4 
Volume 291, number 1 FEBS LETTERS 
nature of the primer template complex, in particular 
with the length of the template, and with the concentra- 
tion ratio of enzyme/primer. In general, there will be 
contributions of both types of inhibition mechanism 
(i.e. chain termination per se and dead end inhibition>, 
but the relative significance of these will vary according 
to the exact concentration relationships and the length 
of the template. Secondly, if an RNA (or DNA) tem- 
plate containing all four bases is used, the same tem- 
plate will serve for testing chain terminators having any 
of these as their base component, with the only modifi- 
cation that n, the number of sites at which the chain 
terminator could potentially be added, must be changed 
in the fitting equation. Similar assays could be set up for 
testing the inhibitory properties against cellular polyme- 
rases, allowing a more objective comparison of the inhi- 
October 1991 
bitory power of the substances against the viral and host 
cell polymerases. 
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